Related Experiment Videos
Cationic vectors in ocular drug delivery
Laura Rabinovich-Guilatt1, Patrick Couvreur, Gregory Lambert
1UMR CNRS 8612, School of Pharmacy, 92296 Châtenay Malabry, France.
Journal of Drug Targeting
|December 29, 2004
Summary
Cationic colloidal drug delivery systems, including liposomes, emulsions, and nanoparticles, enhance ocular drug penetration by utilizing the cornea's negative charge. This approach combats rapid drug loss and improves therapeutic outcomes.
Area of Science:
- Ophthalmic drug delivery
- Colloidal science
- Materials science
Background:
- Ocular drug delivery faces challenges with rapid precorneal drug loss and poor corneal permeability.
- Cationic submicronic vectors offer a promising solution by interacting with the negatively charged corneal surface.
- This strategy aims to increase drug residence time and enhance penetration for improved ocular therapy.
Purpose of the Study:
- To review the formulation of cationic colloids for ophthalmic drug delivery.
- To discuss key formulation parameters influencing the efficacy of cationic vectors.
- To highlight the importance of positive charge in enhancing ocular drug penetration.
Main Methods:
- Review of literature on cationic liposomes, emulsions, and nanoparticles for ophthalmic applications.
- Analysis of formulation parameters including vector type, size, cationic molecule, pH, and drug characteristics.
- Focus on the role of positive charge in ocular drug delivery.
Main Results:
- Cationic colloidal systems demonstrate potential for improved ocular drug delivery.
- Formulation parameters significantly impact the performance of cationic vectors.
- Positive surface charge is crucial for enhanced corneal residence time and penetration.
Conclusions:
- Cationic liposomes, emulsions, and nanoparticles are effective strategies for overcoming ocular drug delivery barriers.
- Optimizing formulation parameters, especially positive charge, is key to successful ophthalmic drug delivery.
- Further research into cationic colloidal systems can lead to advanced ocular therapeutics.